DK166149C - Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne - Google Patents

Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne

Info

Publication number
DK166149C
DK166149C DK100685A DK100685A DK166149C DK 166149 C DK166149 C DK 166149C DK 100685 A DK100685 A DK 100685A DK 100685 A DK100685 A DK 100685A DK 166149 C DK166149 C DK 166149C
Authority
DK
Denmark
Prior art keywords
derivatives
cycotic
fluorphenyl
pyrimidinyl
butyl
Prior art date
Application number
DK100685A
Other languages
Danish (da)
English (en)
Other versions
DK166149B (da
DK100685A (da
DK100685D0 (da
Inventor
Joseph P Yevich
Jr Walter G Lobeck
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK100685D0 publication Critical patent/DK100685D0/da
Publication of DK100685A publication Critical patent/DK100685A/da
Publication of DK166149B publication Critical patent/DK166149B/da
Application granted granted Critical
Publication of DK166149C publication Critical patent/DK166149C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Legs For Furniture In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK100685A 1984-03-06 1985-03-05 Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne DK166149C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58658084A 1984-03-06 1984-03-06
US58658084 1984-03-06
US06/683,309 US4605655A (en) 1984-03-06 1984-12-18 Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US68330984 1984-12-18

Publications (4)

Publication Number Publication Date
DK100685D0 DK100685D0 (da) 1985-03-05
DK100685A DK100685A (da) 1985-09-07
DK166149B DK166149B (da) 1993-03-15
DK166149C true DK166149C (da) 1993-08-09

Family

ID=27079753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100685A DK166149C (da) 1984-03-06 1985-03-05 Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne

Country Status (27)

Country Link
US (1) US4605655A (hu)
KR (3) KR920005113B1 (hu)
AT (1) AT390951B (hu)
AU (1) AU576555B2 (hu)
BE (1) BE901880A (hu)
CA (1) CA1256871A (hu)
CH (1) CH663022A5 (hu)
CY (1) CY1545A (hu)
DE (1) DE3507983A1 (hu)
DK (1) DK166149C (hu)
ES (1) ES8607254A1 (hu)
FI (1) FI84478C (hu)
FR (1) FR2560878B1 (hu)
GB (1) GB2155925B (hu)
GR (1) GR850561B (hu)
HK (1) HK82890A (hu)
HU (1) HU193949B (hu)
IE (1) IE58338B1 (hu)
IT (1) IT1183483B (hu)
LU (1) LU85796A1 (hu)
MX (1) MX9203177A (hu)
MY (1) MY102240A (hu)
NL (1) NL8500628A (hu)
PT (1) PT80058B (hu)
SE (1) SE462429B (hu)
SG (1) SG35590G (hu)
ZA (1) ZA851486B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
HU208690B (en) * 1987-10-26 1993-12-28 Pfizer Process for producing 1-hjeterocyclic sulfonyl-3-(pyrimidinyl piperazinyl)-propane derivatives and pharmaceutical compositions comprising same
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
EP0955296A3 (en) * 1989-04-22 2000-01-19 American Home Products Corporation Tertiary alkyl functionalized piperazine derivatives
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5646281A (en) 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
EP0538693A3 (en) * 1991-10-23 1994-08-17 Squibb & Sons Inc Stereoselective preparation of halophenyl alcohols
TW217382B (hu) * 1991-10-24 1993-12-11 Bristol Myers Squibb Co
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
WO1995028390A1 (fr) * 1994-04-18 1995-10-26 Asahi Kasei Kogyo Kabushiki Kaisha Derive d'adamantane, procede de production et utilisation dudit derive
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2104509B1 (es) * 1995-06-13 1998-07-01 Ferrer Int Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
KR101468553B1 (ko) 2007-05-14 2014-12-09 에스케이바이오팜 주식회사 신규 카바모일옥시 아릴알칸노일 아릴피페라진계 화합물,이를 함유하는 약제학적 조성물 및 상기 화합물 투여에의한 통증, 불안증 및 우울증 치료 방법
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP4153209A1 (en) 2020-05-20 2023-03-29 The Board of Trustees of the University of Illinois Method for treating lysosomal storage diseases with histatin peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2973360A (en) * 1959-10-12 1961-02-28 Paul A J Janssen Certain 1-(2-theonyl lower alkyl)-4-(heterocyclic substituted)-piperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
NL127996C (hu) * 1963-11-19
GB1259685A (en) * 1969-04-03 1972-01-12 Soc D Etudes Prod Chimique Amino-pyrimidine derivatives
BE758380A (fr) * 1969-11-04 1971-04-16 Sumitomo Chemical Co Procede de preparation de derives d'aryl-cetones
GB1307256A (en) * 1970-09-15 1973-02-14 Science Union & Cie Piperazine derivatives and a process for their preparation
BE882836A (fr) * 1979-05-15 1980-08-18 Soc D Etudes Prod Chimique Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique
US4316899A (en) * 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
GB8505662D0 (en) 1985-04-03
FI84478B (fi) 1991-08-30
KR850006402A (ko) 1985-10-05
GR850561B (hu) 1985-07-03
GB2155925B (en) 1987-11-25
AT390951B (de) 1990-07-25
DK166149B (da) 1993-03-15
KR920005694B1 (ko) 1992-07-13
GB2155925A (en) 1985-10-02
SE8501067D0 (sv) 1985-03-05
FI850850L (fi) 1985-09-07
NL8500628A (nl) 1985-10-01
MY102240A (en) 1992-05-15
ATA64985A (de) 1990-01-15
AU3944985A (en) 1985-09-12
KR920005113B1 (ko) 1992-06-26
SE462429B (sv) 1990-06-25
DE3507983A1 (de) 1985-09-12
PT80058B (pt) 1987-10-20
SE8501067L (sv) 1985-09-07
PT80058A (en) 1985-04-01
CY1545A (en) 1991-03-22
KR920005114B1 (ko) 1992-06-26
ES540901A0 (es) 1986-05-16
IT8519773A0 (it) 1985-03-05
FR2560878B1 (fr) 1988-10-14
MX9203177A (es) 1992-07-01
DK100685A (da) 1985-09-07
IT1183483B (it) 1987-10-22
FI850850A0 (fi) 1985-03-01
FI84478C (fi) 1991-12-10
ZA851486B (en) 1985-11-27
SG35590G (en) 1990-07-13
CA1256871A (en) 1989-07-04
AU576555B2 (en) 1988-09-01
LU85796A1 (fr) 1985-12-12
IE850546L (en) 1985-09-06
IE58338B1 (en) 1993-09-08
HUT37781A (en) 1986-02-28
CH663022A5 (de) 1987-11-13
FR2560878A1 (fr) 1985-09-13
ES8607254A1 (es) 1986-05-16
BE901880A (fr) 1985-09-05
HU193949B (en) 1987-12-28
US4605655A (en) 1986-08-12
HK82890A (en) 1990-10-19
DK100685D0 (da) 1985-03-05

Similar Documents

Publication Publication Date Title
DK166149C (da) Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
DK28787D0 (da) Thieno-1,4-diazepinforbindelser samt farmaceutiske praeparater med indhold af saadanne forbindelser
DK160492C (da) Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater
NO820200L (no) Fremgangsmaate til fremstilling av fosforylforbindelser, i foerste rekke heksapyranoseforbindelser samt farmasoeytiske preparater inneholdende disse
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK83386D0 (da) Disaccharid- og trisaccharid-derivater af aelipid aae-typen, praeparaterder indeholder disse samt fremgangsmaade til fremstilling af disse
DK585985A (da) Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af amyotrof lateralsklerose
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK314887A (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK284585D0 (da) 1,4-dihydropyrinderivater, fremgangsmaade til fremstilling af saadanneforbindelser samt laegemiddel indeholdende disse
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK163057C (da) Isoindsolinyl-alkyl-piperaziner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK342187A (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK226488D0 (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK612788D0 (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK617684A (da) 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
DK99085D0 (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK93385D0 (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
PUP Patent expired